Table 1.
Role | Tumor type | Target | Mechanism | Ref |
---|---|---|---|---|
Genetic instability | Osteosarcoma | Topoisomerase I | Promotes gene amplification |
[67] [69] |
Mre11 | Causes ineffective activation of ATM and genetic instability | |||
Lung cancer | Cyclin A, CHK1 | Promotes proliferation of cells with genomic abnormalities | [70] | |
Breast cancer | E2F4 | Inhibits DNA damage repair | [71] | |
Lung adenocarcinoma | Cell in cell | Causes abnormal mitosis and genomic instability | [72] | |
Ferroptosis | Lung cancer | SLC7A11 | p53 3KR induces cell ferroptosis | [76] |
p534KR98]does not induce ferroptosis | [82] | |||
Oesophageal cancer | NRF2 | Causes cell ferroptosis | [79] | |
Microenvironment | Colon cancer | TAM | Renders macrophages in a pro-tumor state | [92] |
NSCLS | ID4 | Leads to tumor angiogenesis | [93] | |
Leukemia | VEGF | Leads to tumor growth and metastasis | [94] | |
Breast cancer | NF-κB | Causes an increased inflammatory response | [95] | |
Colon adenocarcinoma | sIL-1Ra | Generates a pro-inflammatory tumor microenvironment | [96] | |
Stemness | Colon cancer | Lgr5, CD44 | Promotes the expression of markers of CSCs | [99] |
Glioblastoma | WIP | Increases the expression of CSC-like markers | [100] | |
Colorectal cancer | lncRNA | Enhances the stemness | [101] | |
Breast cancer | MiR-200c | Promotes cancer stemness | [102] | |
Lung adenocarcinoma | MiR-324-5p | Promotes cancer stemness | [103] | |
Clinical | Colorectal cancer | Bax, Bak, VDAC | Inhibits apoptosis of tumor cells | [105] |
EFNB2 | Causes chemoresistance | [111] | ||
Osteosarcoma | Procaspase-3 | Causes chemoresistance | [108] | |
Colon cancer | PUMA | Causes chemoresistance | [109] | |
p73 | Inhibits apoptosis of tumor cells | [110] | ||
MDR1 | Causes chemoresistance | [112] |